All of US

Color Genomics burst on the scene in 2015, offering breast cancer susceptibility testing at a fraction of the price of other laboratories.

From the beginning, it was clear that their goal was to scale the availability of genetic testing – including genetic counseling. This approach has drawn some skepticism and it has also drawn some competitors. Their experience with scaling the return of results, says VP of Research and Scientific Affairs Alicia Zhou, seemed like a natural fit with the aims of All of Us, the population screening program funded by the US government. The NIH apparently agreed, giving Color the contract to build out an infrastructure for genetic counseling as All of Us begins its 10-year process of giving back results to participants.

Alicia joins us on the Beagle to discuss Color’s core business ($50 cascade screening? Is that… sustainable?) and some of the new challenges and whether or not they’re hiring…